Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data

Chart Of The Day: Uncertain Outlook For Pfizer Could See Stock Slide To $30

By Investing.com (Pinchas Cohen/Investing.com)Stock MarketsNov 07, 2022 13:25
uk.investing.com/analysis/chart-of-the-day-uncertain-outlook-for-pfizer-could-see-stock-slide-to-30-200545280
Chart Of The Day: Uncertain Outlook For Pfizer Could See Stock Slide To $30
By Investing.com (Pinchas Cohen/Investing.com)   |  Nov 07, 2022 13:25
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
PFE
-0.63%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Pfizer (NYSE:PFE) faces a $16 to $18 billion loss in revenue from 2025 through 2030 as it loses essential patents on five drugs.

The drugs account for 40% of the company's Q3 revenue when its COVID vaccine and antiviral treatment, Paxlovid are excluded. The five drugs are -Eliquis to prevent blood clots, Vyndaqel for cardiomyopathy, Xeljanz for rheumatoid arthritis, Ibrance for breast cancer and Xtandi for prostate cancer.

It is also worth noting that the future of the coronavirus is unclear. If it subsides, it will hit demand for Paxlovid and COVID vaccines which accounted for 52% of revenue for the quarter.

CEO Albert Bourla plans to deal with these future losses by generating revenue from its recent acquisitions, leveraging its in-house drugs and vaccine pipeline as well as focusing on respiratory syncytial virus, migraines, and ulcerative colitis.

However, based on the current chart it seems investors are not convinced about the strategy.

Pfizer Weekly
Pfizer Weekly

The stock has completed a cross between a descending and a symmetrical triangle. Although the descending variety is a more transparent presentation of supply overtaking demand, once there is a breakout, technicians expect the same technical chain reaction to follow both.

Note the rising volume accompanying the downside breakout and the dead drop in that participation when the price rebounds.

I would have preferred a sharper spike as the pattern completed, but bears may feel that the sparse volume of the return move compensates, showing an obvious negative divergence.

Still, the price found resistance by the bottom of the triangle which confirms the overselling within the pattern, and the 200-day moving average is a rational bullish stronghold.

Target

Measure the pattern's height and deduct that figure from the breakout point. The assumption is that the same interest that dominated the price structure will maintain its struggle below it, therefore repeating the $16.31 move from $46.82 to $30.51.

Trading Strategies

Conservative traders should wait for confirmation that resistance persists, such as with a long red candle, before risking a short.

Moderate traders would be content with a weekly close below the pattern.

Aggressive traders could short at will, according to their strategy, incorporating their timing, budget, and temperament. Here is a generic example:

Trade Sample - Aggressive Short Position

  • Entry: $47
  • Stop-Loss: $50
  • Risk: $3
  • Target: $38
  • Reward: $9
  • Risk-Reward Ratio: 1:3

Disclaimer: At the time of publication, the author had no positions in the securities mentioned.

Chart Of The Day: Uncertain Outlook For Pfizer Could See Stock Slide To $30
 

Related Articles

Chart Of The Day: Uncertain Outlook For Pfizer Could See Stock Slide To $30

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email